Home

Directions

Careers

Contact Us

 

DVM Feature Article

PRINCIPLES OF SHOCK
By: Dan Hecht, VMD, Diplomate VECCS
This article outlines the current thought about cardiovascular shock in critical veterinary patients. The discussion includes the definition of shock, the underlying physiology contributing to the different classifications of shock, and the fundamental principles for treatment.  The classifications of shock discussed include hypovolemic, distributive, & cardiogenic.

If you have any questions or comments, please respond to cecomment@westbridge.com

What is SHOCK?
  • The definition of shock is a maldistribution of blood flow such that delivery of oxygen and nutrients is inadequate to organs (essentially a state of inadequate tissue oxygenation ). 
  •  The purpose of tissue oxygenation is to facilitate ATP production.  Make 38 ATP from one molecule of glucose w/O2 and only 2 ATP w/ anaerobic glycolosis, with lactic acid as a by-product.
  • Hemodynamic events during shock contribute to poor cardiac output, hypovolemia, and altered distribution of blood flow, which results in multiple organ failure. 
  • Hypotension is the clinical hallmark of shock, although hypertension can be seen in the early stages of septic shock.
Classifications of shock:
Hypovolemic shock- loss of circulating blood volume
  • Loss of 15% of circulating blood volume will cause tachycardia. 
  • Loss of 15-35% causes hypovolemic shock that can be corrected with vasoconstriction and aggressive fluid replacement. 
  • Loss of 35-45% loss can sometimes be reversed but prognosis is very guarded. 
  • Loss of over 50% is irreversible and always results in death.
Common Causes of Hypovolemic Shock
  • Blood loss-  internal/external bleeding, trauma, tumor
  • Plasma loss – burns, severe exudative dermatitis, peritonitis, pancreatitis, HGE
  • Ascites
  • Fluid and electrolyte loss – vomiting, diarrhea, dehydration, hypoadrenocorticism, hyperthermia
  • Diuresis – hypoadrenocorticism, diabetes insipidus and mellitus
Distributive shock- maldistribution of blood
  • Occurs when there is maldistribution of blood away from vital organs,  ie venous pooling of blood in peripheral vessels
  • Cardiac output (CO) can be low, normal or high
  • Blood pressure can be hypo, normo or hypertensive
Common causes of distributive shock
  • Trauma, Surgical Trauma
  • Anesthetic overdose
  • Endotoxemia
  • Metabolic – renal and hepatic failure, severe alkalosis or acidosis
  • Endocrine – Hypoadrenocorticism, diabetic ketoacidosis
  • Anaphylaxis
  • Neurogenic – spinal or cerebral – Sudden loss of sympathetic tone causes vasodilation and bradycardia.
  • Sepsis – induced by bacterial endotoxins or cytokines.  Can be caused by Gram-positive, gram-negative, viral, protozoal and fungi.  Inflammatory mediators (cytokines) include: histamine, kinins, interleukins, eicosanoids, complement, b-endorphins and tumor necrosis factor. Most result in moderate to severe vasodilatation.  Common causes: peritonitis, pyometra, pyothorax, prostatic or liver abscess, intestinal strangulation or volvulus, HGE, and wound infection.
Cardiogenic shock
  • Severe cardiac insufficiency and decreased cardiac output
  • Only shock which results in increased central venous pressure.
Causes of Cardiogenic Shock
  • Cardiomyopathy – includes thyrotoxic cardiomyopathy
  • Valvular disease
  • Heartworm disease
  • Arrhythmias
  • Congenital heart disease
  • Cardiac drug overdose
  • Pericardial tamponade
  • Pulmonary hypertension
  • Intracardiac neoplasia
Comparison systemic parameters in different types of shock
  Cardiogenic Hypovolemic      Distributive    
SVR     ρ ρ ς
Cardiac Output  ς ς ρς
Central Venous Pressure / PCWP ς  ρ    ς
 
Pathophysiology:
Definitions:
  • Cardiac output (CO) = heart rate (HR) x stroke volume (SV)
  •  Delivery of oxygen (DO2) = CO x oxygen content in the arterioles (CaO2)
  • CaO2 = (1.34 x Hb x SpO2) + (0.003 x PaO2)
  • VO2 = CaO2 - CvO2
  • BP = CO x SVR
 Hypovolemic Shock (HV)
Reduction in blood volume to an extent that ventricular filling, arterial blood pressure (ABP), peripheral blood flow and oxygen utilization by the tissues (VO2) are inadequate to maintain cellular integrity.
Stages of metabolic compensation for shock
  • Pre-load – when decreased will decrease stroke volume, diastolic filling

  • Very early HV shock – decreased venous return will decrease CO which then causes hypotension and hypoperfusion.

  • Baroreceptors – in aortic arch and internal and external carotid arteries – when BP is adequate, they send inhibitory impulses to brain and stim cardioinhibitory center which prevents further vasoconstriction.

  • With hypotension, baroreceptors decrease their inhibitory impulses >> stim of SNS >> adrenal medulla >> catacholamines >> alpha 1 and 2 and Beta 1 and 2 receptors. >> increased HR, vasoconstriction of arteries and veins and contractility >> increased CO, BP, and venous return ( by constricting large veins ).  Splenic contraction can increase circulating blood volume by 20 %.

  • The goal of the SNS is to maintain cerebral and coronary blood flow with less vasoconstriction to these areas at the expense of the rest of the body.

  • CNS Ischemic response  - severe SNS stimulation when BP < 50 mmHg ( usually when < 20 mmHg)

  • SNS - is maximally activated within 30 seconds after hemorrhage

  • RAAS and ADH are activated within 10-30 mins

  • Cushings Reaction - w/ increased CO2, you get increased BP to maintain CBF.

  • Local tissue hypoxia also causes catacholamine (CAT) release from adrenal medulla (AM) and this also increases CO.

  • Clinically see- increased HR, normal or increased BP, bounding pulses, hyperemic MM, rapid CRT.  This can be easily overlooked since the patient may appear normal, but HR is the key

  • Tx is still needed at this time

Middle or early decompensatory stage of shock
  • If fluid loss continues, get increased stimulation of SNS >> reduces blood to skin, muscles, viscera and kidneys in order to save blood for brain and heart.
  • Uneven blood flow is the key to middle shock
  • Opiods and neuropeptides are released due to stress >> peripheral vasodilation
  • Hypoxia worsens – ATP and glucose are depleted >> FFA are metabolized – arachidonic acid >> toxic by-products (prostaglandins [PG], thromboxane A2 and leukotriene) >> can get vasoconstriction, vasodilation, platelet aggregation, lysosomal membrane leakage, cardiac depression and chemotaxis of WBC’s.
  • Hypoxic tissues release – kinins, adenosine, PO4, lactate, K, histamine, CO2, serotonin and proteolytic enzymes

    • Vasoactive substances cause vasodilation, increased capillary permeability, myocardial depression and initiation of the clotting cascade

  • Decreased arterial tone >> capillary stasis, sludging >> lactic acidosis, DIC

  • As hypoxia persists > get cell death

    • As ATP decreases, intracellular Ca increases >> lysosomes rupture >> osmolarity changes and cell membrane leaks and ruptures. - need ATP to maintain the Na-K pump > so get ­ Na and Ca   intracellularly.  Na pulls water in, causing swelling > cell ruptures.  Ca breaks down lysosomal membranes > also destroys cell membranes.

Effects Hypovolemic Shock on tissues
  • Heart – has high O2 demand – needs BP of 60-70mmHg.  Prolonged shock >> acidosis, hypoglycemia >> decreased contractility

  • Kidneys – renin, aldosterone, ADH and angiotension all released >> more vasoconstriction >> decreased tissue perfusion >> MOD (mutiple organ failure / disfunction ) – BP below 60 mmHG >> oliguria and anuria result.  Oliguria – good early indicator of shock.  Acute renal failure (vasomotor nephropathy – from ischemia = can be reversible.

  • Liver and intestines – vasculature compromised >> bacterial endotoxins are absorbed and poorly handled by reticuloendothelial system of liver >> sepsis/endotoxemia.  Also get mucosal ulceration and hemorrhage >> more pooling of blood.  Can even get bowel perforation.  ( Shock Gut )

  • Lungs – Shock lung or Acute respiratory distress syndrome (ARDS), pul edema, thickening of alveolar walls, ventilation-perfusion mismatching.

  • Pancreas – hypoxia >> lysosome fragmentation >> vasoactive and myocardial depressant factor >> inhibits Ca mediated contraction in heart

  • Disseminated Intravascular Coagulation (DIC)- helped by bacterial toxins, hypotension, thrompoplastin (from damaged cells), acidosis and capillary stasis.

Clinical signs of Hypovolemic Shock
  • Low rectal temp
  • Poor pulses
  • Pale MM
  • Prolonged CRT
  • Cool limbs
  • Tachycardia
  • Depressed mentation (hypoxic encephalopathy)
  • Note - in cats, temp > poor response to catacholamines.
 Terminal stages of shock
  • Severe hypoxia even to brain and heart (from SNS stim) >> depresses respiratory and sympathetic center
  • Decreased HR, BP, CO >> cardiac failure
  • Clinical signs – heart failure, severe mental depression, abnormal resp paterns >> CPA to soon follow
  • Even with aggressive Tx – usually irreversible
Reperfusion injury
  • Produces oxygen free radicals, (H2O2, OH and O2)
  • Ishemia alone does not result in all the cellular damage, but also the reperfusion and subsequent inflammation.
Treatment Of [Hypovolemic] Shock
        “ The single most important factor in successful resuscitation from shock is time: rapid expeditious therapy in the early stages may lead to good results, but adequate therapy that is delayed may be ineffective”. (Shoemaker, W.C.)
 ― The goal is to open up unevenly vasoconstricted microcirculatory networks
Fluids – want CVP > 10mmHg
  • Crystalloids- provides volume
    • Dogs 90 mls/kg,  Cats 45 mls/kg
    • Large animals should have 2 catheters
    • 75% leaves intravascular space within 1 hour
  • Colloids- Provide oncotic pressure
    • Fresh whole blood, pRBC’s, plasma, Hetastarch, gelatins, stroma free Hb, albumin, Dextran-40 and 70, Pentastarch and Pentafraction
    • Dose – 10-20 mls/kg/day – dose can be bolused and then followed by same dose over 24 hours.  Dose can be doubled in extreme cases.  Colloids should always be used with crystalloids
    • Like to keep albumin > 2 and assist oncotic pressure with colloids.
    • Watch for volume overload. 
    • Colloids without crystalloids, in volume depleted animals, can decrease GFR.
  • Hypertonic saline – 7.5%
    • Comes as 23%
    • Dose – 4-10 mls/kg
    • Causes rapid shifts of fluid from extravascular to intravascular space
  • HSD – Hypertonic Saline-Dextran solution
    • Used to get benefit of both fluids
    • Dose 5 mls/kg
Fluid selection - Are we treating dehydration or hypoperfusion?
  • Dehydration needs crystalloids ( extravascular )
  • Hypoperfusion ( intravascular ) needs intravascular expanders + / -  positive inotropes.
  • Can have dehydration without hypoperfusion and vice versa. 
  • Need to monitor CVP more, also vitals, BP, - soon - gastric mucosal pH, and serum lactate
End point resuscitation
  • Supranormal end point resuscitation- therapeutic goal is not to return cardiovascular values to normal but rather, supranormal levels.
    • Cardiac index > 50% normal
    • VO2 > 30% normal
    • Blood volume 5-10 ml/kg above normal
  • Hypotensive end point resuscitation
    • closed cavity hemorrhage ( ­ BP can dislodge a clot )
    • cerebral or pulmonary edema
    • want better vitals, but not back to normal
  • Cats especially - start w/ Ό shock dose and re-evaluate - Important to warm up cat before too much fluid is given, especially colloids.
Oxygen
  • Routinely used in all shock patients even if not hypoxemic
  • Benefit – Ex – SpO2 – 95%, PaO2 – 90, PCV 40, – without O2
    • CaO2 – (1.34 x 13.3 x .95) + (0.003 x 90) = 17.2
    • CaO2 = 16.93   +   0.27  = 17.2
  • Give nasal O2 at 50% (FiO2 = .5 ) = SpO2 = 100%, PaO2 = 300
    • CaO2 = (1.34 x 13.3 x 1.0) + (0.003 x 300) = 18.72
    • CaO2 =  17.82   +   0.9  =  18.72
  • Improvement of 8.8%
Glucocorticoids
  • Help stabilize lysosomal and capillary membranes, block arachidonic acid metabolism and stimulate gluconeogenesis
  • Sounds cool but no benefit (based on morbidity or mortality)
Doses:
  • DexSP- 2-8 mg/kg
  • Solu-Delta-Cortef – 15-30 mg/kg
  • Do not use dexamethasone – has propylene glycol – decreases BP
  • Give slow ????????
Cardiovascular support
 Positive inotropes
  • Dobutamine – 2-10 mcg/kg/min
  • Dopamine – 5-10 mcg/kg/min
  • Monitor EKG for arrhythmias
 Vasodilators- Used if normal or high MAP (high systemic vascular resistance SVR), or cardiac failure
  • Nitroprusside – 2 mcg/kg/min
  • Want MAP > 80 and systolic BP >100 mmHg
  • Severe hypotension can occur very quickly – monitor closely
Vasopressors– aim for MAP > 80 and Sys BP > 100
  • Dopamine – 10-20 mcg/kg/min
    • Caution since most organs may have ongoing local vasoconstriction and these vasopressors can actually reduce local blood flow.
    • Monitor urine output, HR, EKG, pulse intensity and MM.
  • Epinephrine – 2-20 mcg/kg/min (alpha and beta)
  • Phenylephrine – 1-3 mcg/kg/min (alpha)
  •  Treating hypotension does not solve the underlying problem. 
Other drugs to consider:
  •  Naloxone – supposedly counteracts effects of neuropetides – not proven to increase survival rate – and it increases pain.
  • Digoxin IV
  • Antibiotics – consider gram neg bacteria from GIT
Monitoring
  • CVP, BP, EKG, HCT, blood gas, HR, pulse intensity, MM, CRT, rectal temp.
  • However – these have been shown in people to tell you where the patient has been, rather than where it is going
  • Future – DO2, VO2, PCWP
Cardiogenic shock
  • Due to valvular disease and cardiomyopathy
  • Pathophysiology
    • Dilated Cardiomyopathy (DCM) – decreased CO due to poor contractility
    • Mitral disease – mitral regurgitation (MR) decreases stroke volume
    • Both cause increased left atrial pressure and pulmonary edema when heart failure occurs.
    • SNS is stimulated and therenin-angiotension-aldosterone system (RAAS) are activated.  This increases pre-load and afterload. The tachycardia from SNS stim does not allow for adequate diastolic filling, decreasing CO even more.
  • Need to differentiate MR from DCM
  • Both can benefit from decreasing pre-load
Treatment
  • Diuretic- Furosemide IV 2-4 mg/kg
  • Venodilator- Nitroglycerine
  • Decrease afterload
    • Nitroprusside
    • Hydralazine
    • Enalopril – reduces pre-load also
  • Positive inotropes
    • Dopamine, dobutamine
    • Digoxin – different mechanism of action
  • Cats with HCM -  need Diltiazem
Septic shock
Pathophysiology
  • Have decreased intravascular fluid volume due to dehydration, fever, and extravasation, peripheral vasodilation, decreased BP and decreased VO2.
  • Initially have increased CO, but not enough to perfuse tissues due to decreased BP.
  • However, this hyperdynamic shock state rapidly deteriorates into a hypodynamic state. 
  • Hyperdynamic state – have brick red MM, fever, tachycardia and hyperpnea (not always recognized for what it is)
  • Hypodynamic – pale MM, tachycardia or bradycardia, prolonged CRT, and cool limbs.
  • Similar stages of shock
Treatment
  • Fluids – large volumes, including colloids – HES may be better than plasma due to less loss through leaky capillary membranes
  • Glucose +/-
  • Potassium  +/-
  • Positive inotropes
  • Vasopressors
  • Antibiotics – KEY
  • Drain any abscess
  • Culture & Sensitivity testing
  • Surgical intervention

 

HOME |Client Center |Referral Center |Holistics|WVH |AECCC |Departments|DVM/Tech CE